Are you Dr. Kim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
11201 Benton St
Loma Linda, CA 92357Phone+1 909-825-7084Fax+1 909-777-3226
Summary
- Dr. William Kim, MD is a board certified psychiatrist in Loma Linda, California. He is currently licensed to practice medicine in California. He is affiliated with Jerry L. Pettis Memorial Veterans' Hospital and is an Assistant Professor at Loma Linda University School of Medicine.
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Psychiatry, 1974 - 1975
- Cleveland Clinic FoundationResidency, Psychiatry, 1972 - 1974
Certifications & Licensure
- CA State Medical License 2015 - 2017
- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 152 citationsDouble-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial CancerToni K. Choueiri, Robert W. Ross, Susanna Jacobus, Ulka N. Vaishampayan, Evan Y. Yu
Journal of Clinical Oncology. 2012-02-10 - 59 citationsLoss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemiaRyan C. Russell, Roxana I. Sufan, Bing Zhou, Pardeep Heir, Severa Bunda
Nature Medicine. 2011-07-01 - 89 citationsA phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological resultsRaj S. Pruthi, Matthew E. Nielsen, Samuel A. Heathcote, Eric Wallen, W. Kim Rathmell
BJU International. 2010-08-01
Grant Support
- Characterization And Therapeutic Targeting Of HIF In LKB1 - Deficient Lung CancerNational Cancer Institute2010–2012
- Imaging Vhl-Associated Tumors With Labile O2 BiosensorsNational Cancer Institute2006–2008
- Imaging Vhl-Associated Tumors With Labile O2 BiosensorsNational Cancer Institute2004–2005